wbldb
home
|
authors
|
theses
Compston, Juliet E.
1
;
Drake, Matthew T.
2
Defining very high fracture risk: is FRAX fit for purpose?
J Bone Miner Res
. August 2020;35(8):1399-1403
©2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
Affiliations
1
Department of Medicine, Cambridge Biomedical Campus, Cambridge, UK
2
Division of Endocrinology, Diabetes, Metabolism, and Nutrition, and Robert and Arlene Kogod Center on Aging,
Mayo Clinic
, Rochester, MN, USA
Links
DOI:
10.1002/jbmr.4134
PubMed:
32696997
WoS:
000554012900001
History
Received: 2020-06-2
Revised: 2020-07-13
Accepted: 2020-07-17
Online: 2020-07-31
Cited Works (16)
Year
Entry
2020
Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F, Johansson H, Lee JK, Liu E, Messina D, Mkinsi O, Pinto D, Prieto-Alhambra D, Saag K, Xia W, Zakraoui L, Reginster J-Y. Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.
Osteoporos Int
. January 2020;31(1):1-12.
2017
Johansson H, Siggeirsdóttir K, Harvey NC, Odén A, Gudnason V, McCloskey E, Sigurdsson G, Kanis JA. Imminent risk of fracture after fracture.
Osteoporos Int
. March 2017;28(3):775-780.
2018
Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Möricke R, López-Romero P. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Lancet
. January 20, 2018;391(10117):230-240.
2019
Kanis JA, Cooper C, Rizzoli R, Reginster J-Y; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO); Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Osteoporos Int
. January 2019;30(1):3-44.
2016
Kanis JA, Harvey NC, Cooper C, Johansson H, Odén A, McCloskey EV; The Advisory Board of the National Osteoporosis Guideline Group. A systematic review of intervention thresholds based on FRAX: a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
Arch Osteoporos
. December 2016;11(1):25.
2019
Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR. Risk of subsequent fracture after prior fracture among older women.
Osteoporos Int
. January 2019;30(1):79-92.
2005
Black DM, Bilezikian JP, Ensrud KE, Greenspan SL, Palermo L, Hue T, Lang TF, McGowan JA, Rosen CJ; PaTH Study Investigators. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.
NEJM
. August 11, 2005;353(6):555-565.
2001
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mellström D, Oefjord ES, Marcinowska-Suchowierska E, Salmi J, Mulder H, Halse J, Sawicki AZ, Mitlak BH. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
NEJM
. May 10, 2001;344(19):1434-1441.
2016
Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, Alexandersen P, Zerbini CAF, Hu M-y, Harris AG, Fitzpatrick LA, Cosman F, Christiansen C; ACTIVE Study Investigators. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial.
JAMA
. August 16, 2016;316(7):722-733.
2020
Adami G, Rossini M, Fassio A, Viapiana O, Gatti D. Comments on Kanis et al. Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures.
Osteoporos Int
. May 2020;31(5):1015-1015.
2018
McClung MR, Brown JP, Diez‐Perez A, Resch H, Caminis J, Meisner P, Bolognese MA, Goemaere S, Bone HG, Zanchetta JR, Maddox J, Bray S, Grauer A. Effects of 24 months of treatment with romosozumab followed by 12 months of denosumab or placebo in postmenopausal women with low bone mineral density: a randomized, double‐blind, phase 2, parallel group study.
J Bone Miner Res
. August 2018;33(8):1397-1406.
2017
Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A. Romosozumab or alendronate for fracture prevention in women with osteoporosis.
NEJM
. October 12, 2017;377(15):1417-1427.
2010
Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD; Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.
Can Med Assoc J
. November 23, 2010;182(17):1864-1873.
2009
van Geel TACM, van Helden S, Geusens PP, Winkens B, Dinant G-J. Clinical subsequent fractures cluster in time after first fractures.
Ann Rheum Dis
. January 2009;68(1):99-102.
2020
Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis: 2020 update.
Endocr Pract
. May 2020;26(suppl 1):1-46.
2017
Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, Hope S, Kanis JA, McCloskey EV, Poole KES, Reid DM, Selby P, Thompson F, Thurston A, Vine N; The National Osteoporosis Guideline Group (NOGG). UK clinical guideline for the prevention and treatment of osteoporosis.
Arch Osteoporos
. December 2017;12(1):1-24.
Cited By (1)
Year
Entry
2022
Iconaru L, Charles A, Baleanu F, Surquin M, Benoit F, Mugisha A, Moreau M, Paesmans M, Karmali R, Rubinstein M, Rozenberg S, Body J-J, Bergmann P. Prediction of an imminent fracture after an index fracture: models derived from the Frisbee cohort.
J Bone Miner Res
. January 2022;37(1):59-67.